NL-OMON48782已完成不适用
Subtyping of Insomnia - Subtyping of Insomnia
Epilepsiecentrum Kempenhaeghe0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •- Patients who are referred to Kempenhaeghe for CBT-I
- •- Age older than 18
- •- Subjective problems with falling asleep or maintaining sleep
- •- A duration of insomnia of more than three months
- •- The sleep disturbance causes clinically significant distress or impairment
- •Patients who live at a driving distance of less than approximately 70 km from Kempenhaeghe. This includes the regions Limburg-Noord, Brabant-Noord, Brabant-Zuidoost, Midden-Brabant and Gelderland-Zuid.
排除标准
- •-Patients with conditions which will prevent taking part in neuropsychological tests, for example due to language problems
- •- Pregnancy
- •- Insomnia that occurs exclusively during the course of a mental disorder or due to medication or drug abuse
- •- Patients who are incompetent to provide informed consent
- •- Patients who are not able to adhere to the study protocol due to severe neurologic or psychiatric disorders, for example schizophrenia or alcohol abuse
研究者
相似试验
尚未招募
不适用
Subtyping of InsomniaNL-OMON28159Sleep Center Kempenhaeghe325
已完成
不适用
Can enhanced insomnia phenotyping aid prediction of treatment response?ACTRN12615000751572Woolcock Institute of Medical Research325
已完成
不适用
Sleep restriction for the treatment of primary insomnia in primary carePrimary InsomniaOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12609000127202niversity of Auckland100
已完成
不适用
Insomnia and affectinsomniaNL-OMON46531VU Medisch Centrum, Amsterdam UMC190
已完成
2 期
Evaluation of an Oral Cannabidiol (CBD)-Terpene Formulation on Sleep Physiology in Participants With InsomniaInsomniaNCT05233761Defined Research125
